Table 2. Characteristics of adult patients initiating ART by age group, 2005–2010.

		Overall		≥50 years		40–49 years		25–39 years		15–24 years
		N	%	N	%	N	%	N	%	N	%
Patients initiating ART		184,689		21,108 (11%)		43,955 (24%)		101,682 (55%)		17,944 (10%)
Year of ART initiation
2005		10,822	6%	1,097	5%	3,107	7%	5,894	6%	724	4%
2006		24,789	13%	2,663	13%	6,325	14%	13,763	14%	2,038	11%
2007		33,981	18%	3,585	17%	7,823	18%	18,976	19%	3,597	20%
2008		36,025	20%	4,121	20%	8,236	19%	19,997	20%	3,671	20%
2009		36,510	20%	4,291	20%	8,429	19%	20,091	20%	3,699	21%
2010		35,219	19%	4,406	21%	8,379	19%	18,950	19%	3,484	19%
2011*		7,343	4%	945	4%	1,656	4%	4,011	4%	731	4%
Sex
Male		65,188	35%	10,405	49%	19,646	45%	32,037	32%	3,100	17%
Female		119,501	65%	10,703	51%	24,309	55%	69,645	68%	14,844	83%
Median (IQR) CD4 cell count at ART initiation, cells/mm3
Overall	CD4 count	161 (77–243)		166 (90–245)		154 (75–234)		159 (74–242)		182 (89–272)
	% missing	33%		33%		32%		33%		37%
Males	CD4 count	144 (63–229)		152 (78–234)		140 (62–223)		141 (59–230)		159 (62–249)
	% missing	32%		32%		31%		32%		36%
Females	CD4 count	170 (86–250)		177 (103–256)		165 (88–242)		166 (82–247)		187 (95–276)
	% missing	32%		34%		34%		34%		37%
WHO stage III/IV at ART initiation
Overall	% WHO III/IV	66,672 64%		8,166 66%		16,660 66%		36,128 63%		5,718 60%
	% missing	43%		41%		42%		43%		47%
Males	% WHO III/IV	25,762 70%		4,089 67%		7,774 70%		12,752 71%		1,147 70%
	% missing	43%		41%		43%		44%		47%
Females	% WHO III/IV	40,910 60%		4,077 62%		8,886 61%		23,376 58%		4,571 56%
	% missing	43%		40%		42%		43%		47%
Documented tuberculosis treatment at ART initiation		4,522 (2%)		470 (2%)		1,149 (3%)		2,580 (3%)		323 2(%)

*ART initiation in 2011 was through June 30^th only for those enrolling in care by the end of 2010.